Market Access: The World of Restrictions and Opportunities – Industry Should Rise to the Challenge
As payers, regulators and providers focus on the pharmaceutical industry to curtail costs, the industry faces a future of increased restrictions on Market Access. To overcome these restrictions, pharmaceutical companies must understand how the evidential requirements of regulators and payers differ and that it is a must to gain early insights into the needs of payers in order to develop the evidence and value messages that match their needs. This article provides a short introduction into Mar...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.